Mayne Pharma
Tony Ramy is an experienced executive in the pharmaceutical and healthcare industry, currently serving as EVP and VP of Sales for the Women's Health Franchise at Mayne Pharma since February 2024. Previously, Tony held multiple roles at Novo Nordisk, including Senior Biopharmaceutical Regional Account Manager and Obesity BU Regional Business Director, where responsibilities involved building relationships with targeted accounts and managing business unit strategies. Tony also served as Senior Director of Business Development at Curia and Sales Manager at Quest Diagnostics. Early career achievements include leading a successful sales team at Schering Pharmaceuticals. Tony holds dual BS degrees in Human Nutrition and Hotel and Restaurant Management from the University of Massachusetts Amherst.
This person is not in any teams
This person is not in any offices
Mayne Pharma
1 followers
Mayne Pharma Group Ltd is an Australia-based specialty pharmaceutical company. The Company is focused on commercializing branded and generic pharmaceuticals. It operates through four segments: Generic Products (GPD), Specialty Brands (SBD), Metrics Contract Services (MCS) and Mayne Pharma International (MPI). The GPD segment is engaged in the manufacture and distribution of generic pharmaceutical products in the United States. The SBD segment markets and distributes specialty branded pharmaceutical products in the United States. The MCS segment is engaged in the provision of contract analytical and pharmaceutical development services to third-party customers in the United States. The MPI segment is engaged in Australian manufacture and sale of branded and generic pharmaceutical product globally and provision of contract manufacturing services to third-party customers within Australia.